BCL2 and cancer: In addition, the natural BH3 mimetic (−)-gossypol has been shown to kill cancer cells via autophagic cell death in Bcl-2-proteins-overexpressing, apoptosis-resistant cancer cells [187], strongly suggesting BH3 mimetics’ anti-tumor effects are not solely dependent on apoptosis.